ESTRO 2024 - Abstract Book

S704

Clinical - Breast

ESTRO 2024

References:

Brunt, A. M., Haviland, J. S., Wheatley, D. A., Sydenham, M. A., Alhasso, A., Bloomfield, D. J., & et al. (2020). Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. The Lancet, Open Access. Publicado em 28 de abril de 2020. DOI: 10.1016/S0140-6736(20)30932-6. Meattini, I., Becherini, C., Boersma, L., Kaidar-Person, O., Marta, G. N., Montero, A., Offersen, B. V., Aznar, M. C., Belka, C., Brunt, A. M., Dicuonzo, S., Franco, P., Krause, M., MacKenzie, M., Marinko, T., Marrazzo, L., Ratosa, I., Scholten, A., Senkus, E., Stobart, H., Poortmans, P., & Coles, C. E. (2018). European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. Radiotherapy and Oncology, 126(1), 1-9. DOI: 10.1016/j.radonc.2017.10.016.

EUROPA Study (ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer). NCT04134598. Azienda Ospedaliero-Universitaria Careggi, janeiro de 2023."

Whelan, T.J., Smith, S., Parpia, S., Fyles, A.W., Bane, A., Liu, F.-F., Rakovitch, E., Chang, L., Stevens, C., Bowen, J., Provencher, S., Théberge, V., et al., for the LUMINA Study Investigators. "Omitting Radiotherapy after Breast Conserving Surgery in Luminal A Breast Cancer." New England Journal of Medicine, 2023 Aug 17;389(7):612-619. doi: 10.1056/NEJMoa2302344.

2960

Digital Poster

Breast cancer in working women: what impact on work and professional reintegration?

Rachida Laraichi 1,2 , Karima Nouni 1,2 , Imane Lahlali 1,2 , Fatima zahra Chraa 1,2 , Chadia Ezouitina 1,2 , Amine Lachgar 1,2 , Hanan El kacemi 1,2 , Tayeb Kebdani 1,2 , Khalid Hasouni 1,2 1 National institute of oncology, radiotherapy department, Rabat, Morocco. 2 Mohamed V University, faculty of medecine and pharmacy, Rabat, Morocco

Purpose/Objective:

The number of women who survive breast cancer and are still of working age after treatment is increasing. However, a cancer diagnosis always means a work stopping. Then, after treatment, professional reintegration constitutes a key step in returning to a “normal” life.

This work aims to assess the impact of breast cancer on the professional activity of working women successfully treated for breast cancer.